checkAd

    Nachrichten - Weitere Nachrichten

    OTX-TKI maintained vision and CSFT comparable to aflibercept every eight weeks, with 89% reduction in treatment burden over a 12-month period OTX-TKI demonstrated no drug-related ocular or systemic serious adverse events in the trial through Month …

    Wertpapier: Ocular Therapeutix

    Posters highlight clinically meaningful improvement in HAE symptoms observed in the first hours after treatment with PHVS416 (deucrictibant immediate-release capsules) as compared to placebo ZUG, Switzerland, June 11, 2023 (GLOBE NEWSWIRE) - …

    Wertpapier: Pharvaris
    09.06.23 · wallstreetONLINE Zentralredaktion
    10.06.23 · EQS Group AG · Basler
    10.06.23 · EQS Group AG · Basler
    10.06.23 · globenewswire · Aptose Biosciences Inc Registered Shs
    10.06.23 · globenewswire · Nkarta
    10.06.23 · globenewswire
    10.06.23 · Sharedeals · Boeing
    10.06.23 · Sharedeals · Volkswagen (VW) Vz
    10.06.23 · Redaktion dts
    10.06.23 · globenewswire · Robex Resources
    10.06.23 · globenewswire · Barrick Gold Corporation
    10.06.23 · Sharedeals
    10.06.23 · globenewswire · HOOKIPA Pharma
    10.06.23 · Redaktion dts
    10.06.23 · Redaktion dts

    Nachrichten Weitere Nachrichten

    864 Leser
    528 Leser
    316 Leser
    284 Leser
    256 Leser
    252 Leser
    220 Leser
    216 Leser
    204 Leser
    164 Leser
    3672 Leser
    3236 Leser
    2628 Leser
    2328 Leser
    2016 Leser
    1756 Leser
    1448 Leser
    1184 Leser
    1164 Leser
    1132 Leser
    19228 Leser
    5696 Leser
    3672 Leser
    3392 Leser
    3236 Leser
    2744 Leser
    2628 Leser
    2596 Leser
    2464 Leser
    2340 Leser
    44236 Leser
    19228 Leser
    16682 Leser
    13520 Leser
    13308 Leser
    11089 Leser
    10893 Leser
    10886 Leser
    10156 Leser
    8984 Leser